Under which DSM‑5 substance use disorder category does diphenhydramine (Benadryl) misuse fall?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diphenhydramine (Benadryl) Misuse Falls Under "Other (or Unknown) Substance Use Disorder"

Diphenhydramine misuse is classified as "Other (or Unknown) Substance Use Disorder" in DSM-5, as it does not fit into the ten specific substance classes explicitly named in the manual. 1

DSM-5 Classification Framework

The DSM-5 consolidated the previous DSM-IV categories of "abuse" and "dependence" into a single diagnosis: Substance Use Disorder, which is then specified by the substance class involved 1. The manual identifies ten specific substance classes:

  • Alcohol
  • Cannabis
  • Hallucinogens
  • Inhalants
  • Opioids
  • Sedatives, hypnotics, or anxiolytics
  • Stimulants
  • Tobacco
  • Caffeine
  • Other (or unknown) substances

Why Diphenhydramine Doesn't Fit Standard Categories

Diphenhydramine is an antihistamine with anticholinergic properties 2. While it has sedating effects, it is not classified as a sedative-hypnotic in the pharmaceutical sense. Its mechanism of action—H1 receptor antagonism with secondary antimuscarinic activity—produces deliriant effects at high doses rather than typical sedative-hypnotic effects 3.

The documented cases of diphenhydramine dependence demonstrate classic DSM-5 substance use disorder criteria including:

  • Tolerance (escalating doses up to 30 tablets daily) 4
  • Withdrawal symptoms (hyperactive delirium, autonomic dysfunction, increased muscle tone) 5
  • Continued use despite harm 4, 6
  • Craving and loss of control 4

Clinical Implications

When documenting diphenhydramine misuse, code it as "Other (or Unknown) Substance Use Disorder" and specify diphenhydramine in the clinical notes. The severity should be graded as mild (2-3 criteria), moderate (4-5 criteria), or severe (6+ criteria) based on the number of DSM-5 substance use disorder criteria met 1.

Important Clinical Pitfalls:

  • Don't overlook over-the-counter medications when taking substance use histories—patients and clinicians often fail to consider OTC drugs as having abuse potential 4
  • Screen patients with psychotic disorders more carefully—there appears to be a link between antipsychotic use and diphenhydramine misuse 4
  • Recognize withdrawal can be severe and life-threatening, requiring careful medical management with gradual tapering and potentially antipsychotic agents like loxapine 5
  • Community pharmacists should monitor for excessive requests, particularly in patients with psychiatric illness or addiction history 4, 6

The substance must be "pharmacologically capable of producing the psychiatric symptoms" per DSM-5 criteria 1, which diphenhydramine clearly is, given its documented ability to produce substantial psychoactive effects including hallucinations, confusion, and dysphoria 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.